Triethylamine → N-{3-Fluoro-4-[(2-{[(4-hydroxypiperidin-1-yl)carbonyl]amino}pyridin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

HRID 2066309Notes

Reaction equation

HRID 2066309 reaction equation
[NH2:1][C:2]1[CH:7]=[C:6]([O:8][C:9]2[CH:14]=[CH:13][C:12]([NH:15][C:16]([C:18]3([C:21]([NH:23][C:24]4[CH:29]=[CH:28][C:27]([F:30])=[CH:26][CH:25]=4)=[O:22])[CH2:20][CH2:19]3)=[O:17])=[CH:11][C:10]=2[F:31])[CH:5]=[CH:4][N:3]=1.[CH2:32]([N:34]([CH2:37][CH3:38])[CH2:35][CH3:36])C.Cl[C:40](OC1C=CC=CC=1)=[O:41].C(OCC)(=[O:51])C>O1CCCC1.O>[F:31][C:10]1[CH:11]=[C:12]([NH:15][C:16]([C:18]2([C:21]([NH:23][C:24]3[CH:25]=[CH:26][C:27]([F:30])=[CH:28][CH:29]=3)=[O:22])[CH2:20][CH2:19]2)=[O:17])[CH:13]=[CH:14][C:9]=1[O:8][C:6]1[CH:5]=[CH:4][N:3]=[C:2]([NH:1][C:32]([N:34]2[CH2:37][CH2:38][CH:40]([OH:41])[CH2:36][CH2:35]2)=[O:51])[CH:7]=1

Participants

7

Procedure

N-{4-[(2-Aminopyridin-4-yl)oxy]-3-fluorophenyl}-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide (150 mg) was dissolved in tetrahydrofuran (4.0 ml) under a nitrogen atmosphere, and triethylamine (0.148 ml) and phenyl chloroformate (0.098 ml) were added dropwise in this order at room temperature, followed by stirring for 10 min. The reaction mixture was stirred after addition of ethyl acetate and water. The organic layer was separated, washed with a 1N aqueous solution of sodium hydroxide, water and brine, and dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure. The residue was dissolved in N,N-dimethylformamide (4.0 ml). 4-Hydroxypiperidine (146 mg) was added at room temperature, followed by stirring for 2 hr. The reaction mixture was partitioned between ethyl acetate and water. The organic layer was washed with a 1N aqueous solution of sodium hydroxide, water and brine in this order, and dried over anhydrous sodium sulfate. The solvent was concentrated under reduced pressure. The resultant residue was purified by silica gel column chromatography (eluent; ethyl acetate, then ethyl acetate:methanol=95:5). Fractions containing the target compound were concentrated under reduced pressure. To the resultant residue was added tert-butyl methyl ether:heptane=1:2 to precipitate a solid. The solid was collected by filtration and dried under aeration to provide the titled compound as white powder (138.0 mg, 71%).

Workup

  1. stirringThe reaction mixture was stirred
  2. customThe organic layer was separated
  3. washwashed with a 1N aqueous solution of sodium hydroxide, water and brine
  4. dry with materialdried over anhydrous sodium sulfate
  5. concentrationThe solvent was concentrated under reduced pressure
  6. dissolutionThe residue was dissolved in N,N-dimethylformamide (4.0 ml)
  7. addition4-Hydroxypiperidine (146 mg) was added at room temperature
  8. stirringby stirring for 2 hr
  9. customThe reaction mixture was partitioned between ethyl acetate and water
  10. washThe organic layer was washed with a 1N aqueous solution of sodium hydroxide, water and brine in this order
  11. dry with materialdried over anhydrous sodium sulfate
  12. concentrationThe solvent was concentrated under reduced pressure
  13. customThe resultant residue was purified by silica gel column chromatography (eluent
  14. additionFractions containing the target compound
  15. concentrationwere concentrated under reduced pressure
  16. additionTo the resultant residue was added tert-butyl methyl ether
  17. customheptane=1:2 to precipitate a solid
  18. filtrationThe solid was collected by filtration
  19. customdried under aeration

Sources & evidence

ORD record
ord-2f441e9640544212a39319d00db69d88
Source dataset
uspto-grants-2012_10
Patent number
US08288538B2

Reaction notes

Loading…